Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Another NDA?
Instead of PTSC trying to find ways to not inform investors of how the Company is doing, they should find ways to inform the investor. Changing the terms with TPL would be a start. Until license fees are announced with each license the investing public will continue to stay away. Just a thought.
Share
New Message
Please login to post a reply